Volume 63, Issue 7 pp. 1287-1289
Brief Report

Parents’ Perspective of Quality of Life of Retinoblastoma Survivors

Atul Batra MD

Atul Batra MD

Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Search for more papers by this author
Raman Kain MD

Raman Kain MD

Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Search for more papers by this author
Mamta Kumari MA

Mamta Kumari MA

Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Search for more papers by this author
Reeja Paul BSc

Reeja Paul BSc

Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Search for more papers by this author
Deepa Dhawan MA

Deepa Dhawan MA

Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Search for more papers by this author
Sameer Bakhshi MD

Corresponding Author

Sameer Bakhshi MD

Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Correspondence to: Sameer Bakhshi, Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110 029, India.

E-mail: [email protected]

Search for more papers by this author
First published: 01 April 2016
Citations: 14

Conflict of interest: Nothing to declare.

Abstract

Health-related quality of life (HRQOL) in retinoblastoma survivors was assessed using parent proxy report of PedsQLTM 4.0 generic core scale. One hundred twenty-two parents of retinoblastoma survivors filled the questionnaire satisfactorily. This was compared with parent-reported HRQOL of 50 siblings. The median age of survivors was 98 (range, 60–247) months and male:female ratio was 2:1. The overall parent-reported HRQOL was significantly worse in survivors as compared to controls (74.4 ± 8.5 vs. 85.1 ± 4.6, P < 0.001). All health domains were significantly affected when compared with controls. None of the baseline and treatment-related factors predicted HRQOL.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.